DMD and Duchenne muscular dystrophy: Here, we set out to combine cellular reprogramming, genome engineering, and in vivo differentiation of PSCs in mouse-mouse and rat-mouse chimeras to generate genetically corrected mouse muscle stem cells that can be exploited to treat DMD by restoring dystrophin expression in dystrophic mice.